questionsmedicales.fr
Cellules
Structures cellulaires
Espace intracellulaire
Cytoplasme
Structures cytoplasmiques
Organites
Ribosomes
Polyribosomes
Polyribosomes : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Polyribosomes : Questions médicales les plus fréquentes",
"headline": "Polyribosomes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Polyribosomes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-06",
"dateModified": "2025-05-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Polyribosomes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Ribosomes",
"url": "https://questionsmedicales.fr/mesh/D012270",
"about": {
"@type": "MedicalCondition",
"name": "Ribosomes",
"code": {
"@type": "MedicalCode",
"code": "D012270",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.284.430.214.190.875.811"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Réticulum endoplasmique rugueux",
"alternateName": "Endoplasmic Reticulum, Rough",
"url": "https://questionsmedicales.fr/mesh/D018870",
"about": {
"@type": "MedicalCondition",
"name": "Réticulum endoplasmique rugueux",
"code": {
"@type": "MedicalCode",
"code": "D018870",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.284.430.214.190.875.811.740.300"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Polyribosomes",
"alternateName": "Polyribosomes",
"code": {
"@type": "MedicalCode",
"code": "D011132",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Timur N Baymukhametov",
"url": "https://questionsmedicales.fr/author/Timur%20N%20Baymukhametov",
"affiliation": {
"@type": "Organization",
"name": "Structural biology department, National Research Center 'Kurchatov Institute', Moscow 123182, Russia."
}
},
{
"@type": "Person",
"name": "Dmitry N Lyabin",
"url": "https://questionsmedicales.fr/author/Dmitry%20N%20Lyabin",
"affiliation": {
"@type": "Organization",
"name": "Institute of Protein Research RAS, Pushchino, Moscow Region 142290, Russia."
}
},
{
"@type": "Person",
"name": "Yury M Chesnokov",
"url": "https://questionsmedicales.fr/author/Yury%20M%20Chesnokov",
"affiliation": {
"@type": "Organization",
"name": "Probe and Electron Microscopy Resource Center, National Research Center 'Kurchatov Institute', Moscow 123182, Russia."
}
},
{
"@type": "Person",
"name": "Ivan I Sorokin",
"url": "https://questionsmedicales.fr/author/Ivan%20I%20Sorokin",
"affiliation": {
"@type": "Organization",
"name": "Institute of Protein Research RAS, Pushchino, Moscow Region 142290, Russia."
}
},
{
"@type": "Person",
"name": "Evgeniya V Pechnikova",
"url": "https://questionsmedicales.fr/author/Evgeniya%20V%20Pechnikova",
"affiliation": {
"@type": "Organization",
"name": "Probe and Electron Microscopy Resource Center, National Research Center 'Kurchatov Institute', Moscow 123182, Russia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Excellent agreement of Norwegian trauma registry data compared to corresponding data in electronic patient records.",
"datePublished": "2023-09-26",
"url": "https://questionsmedicales.fr/article/37752614",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13049-023-01118-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Assessment of immunization data management practices in Cameroon: unveiling potential barriers to immunization data quality.",
"datePublished": "2023-09-27",
"url": "https://questionsmedicales.fr/article/37759205",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12913-023-09965-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mdwgan-gp: data augmentation for gene expression data based on multiple discriminator WGAN-GP.",
"datePublished": "2023-11-13",
"url": "https://questionsmedicales.fr/article/37957576",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12859-023-05558-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Thirty-three myths and misconceptions about population data: from data capture and processing to linkage.",
"datePublished": "2023-01-31",
"url": "https://questionsmedicales.fr/article/37636835",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.23889/ijpds.v8i1.2115"
}
},
{
"@type": "ScholarlyArticle",
"name": "Accuracy of ethnicity records at primary and secondary healthcare services in Waikato region, Aotearoa New Zealand.",
"datePublished": "2024-09-06",
"url": "https://questionsmedicales.fr/article/39236329",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.26635/6965.6445"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures cellulaires",
"item": "https://questionsmedicales.fr/mesh/D022082"
},
{
"@type": "ListItem",
"position": 4,
"name": "Espace intracellulaire",
"item": "https://questionsmedicales.fr/mesh/D042541"
},
{
"@type": "ListItem",
"position": 5,
"name": "Cytoplasme",
"item": "https://questionsmedicales.fr/mesh/D003593"
},
{
"@type": "ListItem",
"position": 6,
"name": "Structures cytoplasmiques",
"item": "https://questionsmedicales.fr/mesh/D022083"
},
{
"@type": "ListItem",
"position": 7,
"name": "Organites",
"item": "https://questionsmedicales.fr/mesh/D015388"
},
{
"@type": "ListItem",
"position": 8,
"name": "Ribosomes",
"item": "https://questionsmedicales.fr/mesh/D012270"
},
{
"@type": "ListItem",
"position": 9,
"name": "Polyribosomes",
"item": "https://questionsmedicales.fr/mesh/D011132"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Polyribosomes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Polyribosomes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Polyribosomes",
"description": "Comment détecte-t-on les polyribosomes ?\nQuels tests sont utilisés pour étudier les polyribosomes ?\nLes polyribosomes sont-ils visibles en microscopie optique ?\nPeut-on quantifier les polyribosomes ?\nLes polyribosomes sont-ils liés à des maladies ?",
"url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Data+Accuracy&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Polyribosomes",
"description": "Quels symptômes sont liés aux dysfonctionnements des polyribosomes ?\nLes polyribosomes affectent-ils la croissance cellulaire ?\nY a-t-il des symptômes neurologiques associés ?\nLes polyribosomes influencent-ils le métabolisme ?\nPeut-on observer des symptômes immunitaires ?",
"url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Data+Accuracy&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Polyribosomes",
"description": "Comment prévenir les dysfonctionnements des polyribosomes ?\nLes vaccinations influencent-elles les polyribosomes ?\nY a-t-il des facteurs environnementaux à surveiller ?\nL'exercice physique a-t-il un impact ?\nDes contrôles médicaux réguliers sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Data+Accuracy&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Polyribosomes",
"description": "Comment traiter les dysfonctionnements des polyribosomes ?\nDes médicaments peuvent-ils affecter les polyribosomes ?\nY a-t-il des approches nutritionnelles ?\nLes thérapies géniques peuvent-elles aider ?\nDes traitements expérimentaux existent-ils ?",
"url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Data+Accuracy&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Polyribosomes",
"description": "Quelles complications peuvent survenir avec des polyribosomes défectueux ?\nLes polyribosomes affectent-ils le cancer ?\nY a-t-il des risques de maladies neurodégénératives ?\nLes infections peuvent-elles aggraver les problèmes de polyribosomes ?\nDes troubles de croissance peuvent-ils survenir ?",
"url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Data+Accuracy&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Polyribosomes",
"description": "Quels facteurs génétiques influencent les polyribosomes ?\nL'alimentation joue-t-elle un rôle ?\nLe stress oxydatif impacte-t-il les polyribosomes ?\nLes toxines environnementales sont-elles un risque ?\nLe vieillissement affecte-t-il les polyribosomes ?",
"url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Data+Accuracy&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecte-t-on les polyribosomes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les polyribosomes sont généralement observés par microscopie électronique."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour étudier les polyribosomes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse par centrifugation et l'électrophorèse sur gel sont courantes."
}
},
{
"@type": "Question",
"name": "Les polyribosomes sont-ils visibles en microscopie optique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils nécessitent une microscopie électronique pour être visualisés."
}
},
{
"@type": "Question",
"name": "Peut-on quantifier les polyribosomes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, par des méthodes comme la spectrophotométrie et l'analyse d'images."
}
},
{
"@type": "Question",
"name": "Les polyribosomes sont-ils liés à des maladies ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans leur formation peuvent être associées à certaines pathologies."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés aux dysfonctionnements des polyribosomes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles de la synthèse protéique peuvent entraîner des symptômes variés."
}
},
{
"@type": "Question",
"name": "Les polyribosomes affectent-ils la croissance cellulaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une synthèse protéique altérée peut inhiber la croissance cellulaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles neurologiques peuvent survenir si la synthèse protéique est affectée."
}
},
{
"@type": "Question",
"name": "Les polyribosomes influencent-ils le métabolisme ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils jouent un rôle clé dans le métabolisme cellulaire par la synthèse des protéines."
}
},
{
"@type": "Question",
"name": "Peut-on observer des symptômes immunitaires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies dans les polyribosomes peuvent affecter la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir les dysfonctionnements des polyribosomes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir ces dysfonctionnements."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles les polyribosomes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent améliorer la réponse immunitaire et la fonction des polyribosomes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux à surveiller ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines peut affecter la fonction des polyribosomes."
}
},
{
"@type": "Question",
"name": "L'exercice physique a-t-il un impact ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la santé cellulaire et la fonction des polyribosomes."
}
},
{
"@type": "Question",
"name": "Des contrôles médicaux réguliers sont-ils nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans de santé réguliers peuvent aider à détecter des anomalies précocement."
}
},
{
"@type": "Question",
"name": "Comment traiter les dysfonctionnements des polyribosomes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la cause sous-jacente, souvent par des thérapies ciblées."
}
},
{
"@type": "Question",
"name": "Des médicaments peuvent-ils affecter les polyribosomes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent moduler la synthèse protéique via les polyribosomes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des approches nutritionnelles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une nutrition adéquate peut soutenir la synthèse protéique et la fonction des polyribosomes."
}
},
{
"@type": "Question",
"name": "Les thérapies géniques peuvent-elles aider ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent corriger des défauts génétiques affectant les polyribosomes."
}
},
{
"@type": "Question",
"name": "Des traitements expérimentaux existent-ils ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours sur des traitements ciblant les polyribosomes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des polyribosomes défectueux ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles métaboliques et des maladies dégénératives peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les polyribosomes affectent-ils le cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans leur fonction peuvent contribuer à la progression du cancer."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de maladies neurodégénératives ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dysfonctionnements des polyribosomes sont liés à des maladies comme Alzheimer."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles aggraver les problèmes de polyribosomes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent perturber la synthèse protéique via les polyribosomes."
}
},
{
"@type": "Question",
"name": "Des troubles de croissance peuvent-ils survenir ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans les polyribosomes peuvent entraîner des retards de croissance."
}
},
{
"@type": "Question",
"name": "Quels facteurs génétiques influencent les polyribosomes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mutations génétiques peuvent affecter la formation et la fonction des polyribosomes."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une carence en nutriments essentiels peut perturber la fonction des polyribosomes."
}
},
{
"@type": "Question",
"name": "Le stress oxydatif impacte-t-il les polyribosomes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut endommager les ribosomes et affecter leur fonction."
}
},
{
"@type": "Question",
"name": "Les toxines environnementales sont-elles un risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines peut nuire à la synthèse protéique via les polyribosomes."
}
},
{
"@type": "Question",
"name": "Le vieillissement affecte-t-il les polyribosomes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut entraîner une diminution de l'efficacité des polyribosomes."
}
}
]
}
]
}
The Norwegian Trauma Registry (NTR) is designed to monitor and improve the quality and outcome of trauma care delivered by Norwegian trauma hospitals. Patient care is evaluated through specific qualit...
We validated 49 of the 118 variables registered in the NTR by comparing those with the corresponding ones in electronic patient records for 180 patients with a trauma diagnosis admitted in 2019 at eig...
Almost perfect agreement (AC...
All tested variables in the Norwegian Trauma Registry displayed excellent agreement with the corresponding variables in electronic patient records. Variables in the registry that showed missing data n...
One crucial obstacle to attaining universal immunization coverage in Sub-Saharan Africa is the paucity of timely and high-quality data. This challenge, in part, stems from the fact that many frontline...
A descriptive cross-sectional study was conducted, involving health districts and health facilities in all 10 regions in Cameroon selected by a multi-stage sampling scheme. Structured questionnaires a...
A total of 265 facilities in 68 health districts were assessed. There was limited availability of some data recording tools like vaccination cards (43%), maintenance registers (8%), and stock cards (5...
Our findings unveil important gaps in data collection practices at the facility level that could adversely affect Cameroon's immunization data quality. It highlights the urgent need for systematic cap...
Although gene expression data play significant roles in biological and medical studies, their applications are hampered due to the difficulty and high expenses of gathering them through biological exp...
In this study, an improved data augmentation approach MDWGAN-GP, a generative adversarial network model with multiple discriminators, is proposed. In addition, a novel method is devised for enriching ...
The experimental results have demonstrated that compared with other state-of-the-art methods, the MDWGAN-GP method can produce higher quality generated gene expression data in most cases....
Databases covering all individuals of a population are increasingly used for research and decision-making. The massive size of such databases is often mistaken as a guarantee for valid inferences. How...
Ethnicity is an important variable, and in Aotearoa New Zealand it is used to monitor population health needs, health services outcomes and to allocate resources. However, there is a history of underc...
Through individual record linkage, prospective self-reported ethnicity, collected using New Zealand Census and Ministry of Health - Manatū Hauora ethnicity protocol as a "gold standard", was compared ...
Māori were undercounted in secondary NHI (32.5%) and primary care (31.3%) datasets compared to self-reported (34.6%). Between 9.5-11% of individuals had a different ethnicity recorded in health datase...
Routine health datasets fail to adequately collect ethnicity, particularly for those with multiple ethnicities. Inaccuracies disproportionately affect Māori and urgent efforts are needed to improve co...
Key to small-angle scattering (SAS) maturing and becoming a mainstream structural biology technique was the work done by the SAS community to establish standards for data quality, model validation and...
An objective of the Information Revolution Roadmap of Ethiopia's Health Sector Transformation Plan was to improve health management information system (HMIS) data quality and data use at the point of ...
We conducted an interpretative qualitative study across all 11 health centers in 3 subcities of Addis Ababa, Ethiopia: Yeka, Akaki-Kaliti, and Ledeta. A total of 40 key informant interviews and 6 focu...
Our findings indicate that the main drivers of data quality and use at the point of service delivery were the use of the Connected Woreda strategy and its tools, capacity-building activities including...
Improvements in quality and use of HMIS data at health facilities are expected to result in delivering better-quality health services to the community as data enable health workers to identify gaps in...
Wearable recordings of neurophysiological signals captured from the wrist offer enormous potential for seizure monitoring. Yet, data quality remains one of the most challenging factors that impact dat...
Surveillance modernization efforts emphasize the potential use of electronic health record (EHR) data to inform public health surveillance and prevention. However, EHR data streams vary widely in thei...
We developed a validation process for the Multi-State EHR-Based Network for Disease Surveillance (MENDS) pilot project to identify and resolve data quality issues that could affect chronic disease pre...
We identified gaps in the EHR databases of data contributors and in the processes to extract, map, integrate, and analyze their EHR data. Examples of source-data problems included missing data on race...
Validation protocols identified critical errors in both EHR source data and in the processes used to transform these data for analysis. Our experience highlights the value and importance of data valid...
Despite great promise, trials that ascertain patient clinical data from electronic health records (EHR), referred to here as "EHR-sourced" trials, are limited by uncertainty about how existing trial s...
We describe a demonstration project that used EHR data to complement data collected for a contemporary multi-center pharmaceutical industry outcomes trial, and how a central coordinating center suppor...
While broadening the type of sites able to participate in EHR-sourced trials may lead to greater generalizability and improved enrollment, sites with fewer technical resources may require additional s...